Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imukin (interferon gamma) in Friedreich's ataxia
2015-002432-40Phase 2Completed
- Sponsor
- La Nostra Famiglia
- Start
- May 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon gamma-1b in Friedreich ataxia (FA), sponsored by La Nostra Famiglia. Primary endpoint: Safety of interferon gamma treatment. Started May 2021; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2015-002432-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002432-40.